Agile Therapeutics
AGRX
$0.38
Share price
-5.47%
Change (1 day)
-90.94%
Change (1 year)
Categories
Earnings for Agile Therapeutics (AGRX)
Earnings in 2023 (TTM): -$13.05 M
According to Agile Therapeutics 's latest financial reports the company's current earnings (TTM) are -$13.05 M. In 2022 the company made an earning of -$4.79 M an increase over its 2021 earnings that were of -$70.98 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Agile Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$13.05 M | 172.57% |
| 2022 | -$4.79 M | -93.26% |
| 2021 | -$70.98 M | 45.62% |
| 2020 | -$48.75 M | 161.98% |
| 2019 | -$18.61 M | -2.78% |
| 2018 | -$19.14 M | -27.47% |
| 2017 | -$26.39 M | -10.16% |
| 2016 | -$29.37 M | -14.2% |
| 2015 | -$34.24 M | 88.45% |
| 2014 | -$18.17 M | 41.72% |
| 2013 | -$12.82 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -163,826.24% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -25,138.32% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -23,360.27% | 🇺🇸 USA |
 TherapeuticsMD TXMD | -$39.67 M | 204.02% | 🇺🇸 USA |
 Antares Pharma ATRS | $65.88 M | -604.92% | 🇺🇸 USA |